Join DS2 at RNA Leaders USA 2026
DS2 will be at RNA Leaders USA in Boston from September 23 to 25, across the technical track and the business forum and meeting customers and partners around the sessions. Put a time in with us.
Let's Connect in Boston
RNA Leaders USA gathers 300 or more attendees and 70 speakers across mRNA, oligonucleotides and next-generation RNA, with drug discovery leads from Alnylam, Novo Nordisk, Novartis, Sanofi, AstraZeneca and Moderna alongside the CSOs and CTOs of the companies moving candidates into the clinic. RNA programs are demanding on handling, storage and temperature, and we provide industry-leading solutions across the entire connected sample supply chain. Cold chain with a temperature record that holds up, kitting for clinical sample collection, courier routes that respect a short stability window, biostorage for long-term sample sets, and integration that puts results back into your systems. We'd love to talk through what your candidate needs as it moves from preclinical into first-in-human.
We often find during these events that the diary fills up quickly. Use the form and we'll block a time for you to meet our team while availability lasts.
Why Attend RNA Leaders USA 2026?
Informa Connect frames RNA Leaders USA as "Powering Partnerships to Propel the RNA Pipeline in North America," and describes the Congress as focusing on the science and innovation behind RNA technologies, bringing experts together to explore breakthroughs in nucleic acids.
Co-located with Biotech Week Boston: Published numbers for 2026 are 300 or more attendees and 70 or more speakers, co-located with Biotech Week Boston and its 5,000-plus pharma, biotech, investor, academic and solution provider audience.
One congress, three streams: The programme splits into an RNA Leaders Business Forum and a Technical Track on day one, then opens into parallel streams for oligonucleotide-based therapeutics and mRNA and next-generation RNA, covering translational and enabling platforms, pre-clinical and analytical development, delivery, and clinical advancements for ASOs and siRNA.
A keynote close on day three: Day three closes with a keynote panel on RNA drug discovery featuring Alnylam, Novo Nordisk, Novartis and Sanofi, preceded by a Women in RNA networking lunch and a spotlight on Montreal.
Why Meet with DS2?
RNA candidates are unforgiving about handling. Temperature excursions, thaw cycles and long transit times all show up in the data, and the samples coming back from a clinical site carry the same constraints as the material going out. DS2 builds and runs that layer, with the documentation to show the range held end to end. What we do:
- Diagnostic and specimen collection kit design, assembly and fulfillment
- Kit-to-patient and direct-to-patient distribution
- Medical courier services, including STAT and next-flight-out specimen transport
- Cold chain and temperature-controlled logistics, with the documentation to prove the range held
- Biostorage and biorepository services
- Mobile phlebotomy and specimen collection
- LIS, LIMS and EMR integration, including HL7 and FHIR
- Chain of custody and compliance documentation
Cold chain and temperature-controlled logistics, kit design for clinical sample collection, courier routes built around stability windows, biostorage and LIS and LIMS integration. We're looking forward to talking it through in Boston.
Speaking Faculty
A selection from the 70 or more speakers published for 2026.
Muthiah Manoharan
Alnylam Pharmaceuticals
Senior Vice President, Drug Innovation and Distinguished Research Scientist
Karina Thorn
Novo Nordisk
Vice President, Head of Nucleic Acid Research
Malgorzata Gonciarz
Novartis
Global Head, xRNA Therapeutics
Chandra Vargeese
Wave Life Sciences
Chief Technology Officer
Annette Bak
AstraZeneca
Head of Advanced Drug Delivery
Edward Miracco
Moderna
Head of Enterprise AI Enablement
Shaan Gandhi
Pfizer
Vice President and Head of Partnerships, PAVE
Elena Diez Cecilia
Johnson & Johnson
Senior Director, External Innovation DPDS
Isabel Aznarez
Stoke Therapeutics
Co-founder and Chief Technology Officer
Ranjan Batra
Dyne Therapeutics
Chief Scientific Officer
Tasuku Kitada
Strand Therapeutics
President and Head of R&D
Uli Stilz
Flagship Pioneering
Senior Partner, Pioneering Medicines Partnerships
The full speaker list is on the official speakers page.
The Agenda, Day by Day
Times below are as published by Informa Connect. The complete session list across all three days and every stream is on the official agenda pages.
Day One · Wednesday, September 23, 2026
Biotech Week Boston fitness class
Registration
Workshop 1: RNA Therapeutics Valuation Workshop, Business Forum
Jeff Raphael, Founder and Managing Partner, OmniScope Partners
Workshop 2: Targeted Delivery of Oligos and mRNA, Technical Track
Haig Aghajanian, Capstan Therapeutics; Pintu Kanjial, Strand Therapeutics; Siddharth Iyer, Wyss Institute, Harvard University
Workshop 3: RNA Leaders CEO Forum
Nathaniel Wang, Replicate Bioscience; Mehdi Pirouz, Noara Therapeutics; Ahmet Berkyurek, CamMed Therapeutics
Workshop 4: Regulatory and CMC Innovation
Mayurbhai Patel, Vice President of CMC and Chemistry Development, Judo Bio
RNA Leaders welcome and chair opening address
Jade Osei-Tutu, Head of RNA Leaders, Informa Connect
Parallel sessions
External innovation pathways with Malgorzata Gonciarz, Novartis; influenza mRNA vaccine mechanisms with Shraddha Sharma, Sanofi; RNAi targeting INHBE with Chandra Vargeese, Wave Life Sciences
Afternoon break
Panels: East meets West in APAC and North America; the role of AI in RNA; funding and partnerships in genetic medicines; targeted delivery strategies
Uli Stilz, Flagship Pioneering; Edward Miracco, Moderna; Shaan Gandhi, Pfizer; Annette Bak, AstraZeneca
Drinks reception
Day Two · Thursday, September 24, 2026
Biotech Week Boston Fun Run
Chair remarks across all three streams
Oligo-based therapeutics: translational and enabling platforms
Anders Näär, UC Berkeley; Tamar Grossman, La Jolla Labs; Konstantina Skourti-Stathaki, n-Lorem Foundation; Jun Zhou, WuXi TIDES
mRNA and next-gen RNA: translational and enabling
Elisabetta Morini, Massachusetts General Hospital; Tao Pan, University of Chicago; Brittany Morgan, University of Notre Dame; Rok Sekirnik, Sartorius BIA Separations
Business Forum innovation presentations
Amplitude Therapeutics, Amrixa Pharmaceuticals, ParcelBio, Samyang Biopharm USA and Therna Biosciences
Morning break
Parallel sessions on pre-clinical and analytical development
Avidity Biosciences, Tangram Therapeutics, Bachem, Circurna, Circio, QurAlis and the University of British Columbia
Business Forum: Investor Insights Question Circle
Soyoung Park, 1004 Venture Partners; Max Colbert, Medical Excellence Capital; Mark Springel, Vida Ventures; Phil Lavin, Melior Capital Management
Lunch
Delivery streams and Pharma Insights Question Circle
Ranjan Batra, Dyne Therapeutics; Sizhen Li, Sanofi; Pedro Morais, Bayer; Philipp Schreppel, Ethris; Elena Diez Cecilia, Johnson & Johnson
RNA Showdown and Partnering Hour
Coaches to the networking party
Biotech Week Boston Festival Party at the Museum of Science
Day Three · Friday, September 25, 2026
Chair remarks
Praveen Kumar Pogula, QurAlis; Jacob Miner, Sanofi
ASOs clinical advancements
Isabel Aznarez, Stoke Therapeutics; Zdravka Medarova, TransCode Therapeutics; Wuming Yan, Asymchem
mRNA and next-gen RNA: non-linear innovation
Lubor Gaal, Circio; Michael Lam, Sail Biomedicines; Peter Weinstein, Circurna
Morning networking break
siRNA and mRNA clinical advancements
Roger Chang, Arrowhead; Marc Abrams, SanegeneBio; Chris Li, Hongene; Dave Hava, Alltrna; Tasuku Kitada, Strand Therapeutics
Lunch, or the Women in RNA networking lunch and sparkling reception
Chair remarks, spotlight on Montreal
David Ferland-McCollough, Innovation Advisor, AReNA
Keynote panel: RNA Drug Discovery, Fostering the Next Wave of RNA Medicines
Karina Thorn, Novo Nordisk; Muthiah Manoharan, Alnylam; Malgorzata Gonciarz, Novartis; Shraddha Sharma, Sanofi
Closing remarks
Jade Osei-Tutu, Head of RNA Leaders, Informa Connect
Useful RNA Leaders USA Resources
The official event page; everything here is published by Informa Connect.
View AgendaDay one, with days two and three linked from it.
SpeakersThe published faculty.
Who Will You Meet?The attendee profile.
PartneringONEHow one-to-one meetings work.
Venue and TransportationGetting to the Hynes.
Book Your HotelThe official room block.
Group RatesDiscounts for three or more delegates.
Book NowPass types and pricing.
RNA Leaders USA 2026 FAQ
General
Fees & registration
Venue & travel
See You in Boston
Boston, September 23 to 25. Tell us where your RNA programme is in its journey and we'll block out time to talk about handling, transport and storage.